Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Johnson

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|June 18, 2002
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)Agneta Nordberg, Ewa Hellström-Lindahl, Mandy Lee, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|May 22, 2010
Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodiesHans-Gert Bernstein, Mary Johnson, Robert H Perry, et al.
Molecular Medicine (Cambridge, Mass.)|March 9, 2022
Vascular hyperacetylation is associated with vascular smooth muscle dysfunction in a rat model of non-obese type 2 diabetesMaria Alicia Carrillo-Sepulveda, Nicole Maddie, Christina Mary Johnson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
The effect of drug treatment on neurogenesis in Parkinson's diseaseSean S O'Sullivan, Mary Johnson, David R Williams, et al.
Journal of Molecular Neuroscience : MN|June 13, 2002
Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesteraseMarie M Svedberg, Anne-Lie Svensson, Mary Johnson, et al.
Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 8, 2017
Quantitative neuropathology: an update on automated methodologies and implications for large scale cohortsLauren Walker, Kirsty E McAleese, Mary Johnson, et al.
Journal of the Neurological Sciences|October 7, 2004
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathologyThanasak Teaktong, Alison J Graham, Jennifer A Court, et al.
Acta Neuropathologica|March 12, 2015
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypesLauren Walker, Kirsty E McAleese, Alan J Thomas, et al.
Journal of Chemical Neuroanatomy|April 23, 2003
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's diseaseMargaret A Piggott, Jonathan Owens, John O'Brien, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|June 18, 2002
Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)Agneta Nordberg, Ewa Hellström-Lindahl, Mandy Lee, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|May 22, 2010
Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodiesHans-Gert Bernstein, Mary Johnson, Robert H Perry, et al.
Molecular Medicine (Cambridge, Mass.)|March 9, 2022
Vascular hyperacetylation is associated with vascular smooth muscle dysfunction in a rat model of non-obese type 2 diabetesMaria Alicia Carrillo-Sepulveda, Nicole Maddie, Christina Mary Johnson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
The effect of drug treatment on neurogenesis in Parkinson's diseaseSean S O'Sullivan, Mary Johnson, David R Williams, et al.
Journal of Molecular Neuroscience : MN|June 13, 2002
Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesteraseMarie M Svedberg, Anne-Lie Svensson, Mary Johnson, et al.
Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 8, 2017
Quantitative neuropathology: an update on automated methodologies and implications for large scale cohortsLauren Walker, Kirsty E McAleese, Mary Johnson, et al.
Journal of the Neurological Sciences|October 7, 2004
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathologyThanasak Teaktong, Alison J Graham, Jennifer A Court, et al.
Acta Neuropathologica|March 12, 2015
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypesLauren Walker, Kirsty E McAleese, Alan J Thomas, et al.
Journal of Chemical Neuroanatomy|April 23, 2003
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's diseaseMargaret A Piggott, Jonathan Owens, John O'Brien, et al.
Pageof 9